11-75587703-A-G
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The ENST00000304771.8(MAP6):āc.1798T>Cā(p.Ser600Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000398 in 1,610,490 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
ENST00000304771.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MAP6 | NM_033063.2 | c.1798T>C | p.Ser600Pro | missense_variant | 4/4 | ENST00000304771.8 | NP_149052.1 | |
LOC105369391 | NR_145823.1 | n.86+4422A>G | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MAP6 | ENST00000304771.8 | c.1798T>C | p.Ser600Pro | missense_variant | 4/4 | 1 | NM_033063.2 | ENSP00000307093 | A2 | |
ENST00000527803.1 | n.86+4422A>G | intron_variant, non_coding_transcript_variant | 4 | |||||||
MAP6 | ENST00000526740.3 | c.811T>C | p.Ser271Pro | missense_variant | 4/4 | 5 | ENSP00000434278 | A2 |
Frequencies
GnomAD3 genomes AF: 0.000389 AC: 58AN: 149126Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000700 AC: 176AN: 251480Hom.: 1 AF XY: 0.000625 AC XY: 85AN XY: 135918
GnomAD4 exome AF: 0.000399 AC: 583AN: 1461364Hom.: 5 Cov.: 31 AF XY: 0.000407 AC XY: 296AN XY: 726948
GnomAD4 genome AF: 0.000389 AC: 58AN: 149126Hom.: 0 Cov.: 32 AF XY: 0.000344 AC XY: 25AN XY: 72764
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | May 25, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at